The Selective Estrogen Receptor Modulator DT56a...

The Selective Estrogen Receptor Modulator DT56a...

The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women

Objective: The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on platelet function in normal and thrombophilic women being treated for severe menopausal symptoms.

Menopause: The Journal of The North American Menopause Society Vol. 18, No. 3, pp. 285/288

The Selective Estrogen Receptor Modulator DT56a...

購買商品